The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors-Reference-Cited by-同舟云学术

The Tumor Antigen Cyclin B1 Hosts Multiple CD4 T Cell Epitopes Differently Recognized by Pre-Existing Naive and Memory Cells in Both Healthy and Cancer Donors

Published:2015-07-01 Issue:4 Volume:195 Page:1891-1901
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Chevaleyre Claire,Benhamouda Nadine,Favry Emmanuel,Fabre Elizabeth,Mhoumadi Anais,Nozach Hervé,Marcon Elodie,Cosler Guillaume,Vinatier Emeline,Oudard Stephane,Hans Stephane,Le Pimpec-Barthes Françoise,Bats Anne-Sophie,Castelli Florence A.,Tartour Eric,Maillère Bernard

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference61 articles.

1. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

2. A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

3. Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes

4. A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.;Schultz;Cancer Res.,2000

5. A MAGE-1 peptide recognized on HLA-DR15 by CD4+ T cells

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of hub genes and diagnostic efficacy for triple-negative breast cancer through WGCNA and Mendelian randomization;Discover Oncology;2024-04-12

2. An ultra pH-responsive peptide nanocarrier for cancer gene therapy;Journal of Materials Chemistry B;2023

3. Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis;Journal of Healthcare Engineering;2022-09-19

4. Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention;Frontiers in Immunology;2021-08-30

5. Tight Interplay Between Therapeutic Monoclonal Antibodies and the Tumour Microenvironment in Cancer Therapy;Advances in Experimental Medicine and Biology;2020